Paper28606
Mechanism of interferon action. Properties of an interferon-mediated ribonucleolytic activity from mouse L929 cells.
Eppstein DA and 1 other. Virology, 1978. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. Mechanism of interferon action. Properties of an interferon-mediated ribonucleolytic activity from mouse L929 cells. Papers, record 28606. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28606
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanism of interferon action. Properties of an interferon-mediated ribonucleolytic activity from mouse L929 cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| RNA, Viral | Major topic |
| Ribonucleases | Major topic |
| Enzyme Activation | |
| Hydrogen-Ion Concentration | |
| L Cells | |
| Magnesium | |
| Potassium | |
| Protein Biosynthesis | |
| RNA | |
| Reoviridae | |
| Viral Proteins |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27595182 | New advances in our understanding of the "unique" RNase L in host pathogen interaction and immune signaling. | Cytokine | 2020 | https://conductscience.org/library/papers/27595182 | PubMed |
| 26760998 | The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/26760998 | PubMed |
| 17681844 | A scientific journey through the 2-5A/RNase L system. | Cytokine Growth Factor Rev | 2007 | https://conductscience.org/library/papers/17681844 | PubMed |
| 7079179 | Structural requirements of (2'-5') oligoadenylate for protein synthesis inhibition in human fibroblasts. | Nucleic Acids Res | 1982 | https://conductscience.org/library/papers/7079179 | PubMed |
| 6947212 | 5'-O-Monophosphoryladenylyl(2' goes to 5')adenylyl(2' goes to 5')adenosine is an antagonist of the action of 5'-O-triphosphoryladenylyl-(2' goes to 5')adenylyl(2' goes to 5')adenosine and double-stranded RNA. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6947212 | PubMed |
| 6865941 | Growth regulation of melanoma cells by interferon and (2'-5')oligoadenylate synthetase. | Mol Cell Biol | 1983 | https://conductscience.org/library/papers/6865941 | PubMed |
| 6676984 | Biosynthetic human interferon treatment of herpetic keratitis. | Trans Am Ophthalmol Soc | 1983 | https://conductscience.org/library/papers/6676984 | PubMed |
| 6300696 | Xyloadenosine analogue of (A2'p)2A inhibits replication of herpes simplex viruses 1 and 2. | Nature | 1983 | https://conductscience.org/library/papers/6300696 | PubMed |
| 6244560 | Kinetics of decay in the expression of interferon-dependent mRNAs responsible for resistance to virus. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6244560 | PubMed |
| 6244537 | Double-stranded RNA inhibits a phosphoprotein phosphatase present in interferon-treated cells. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6244537 | PubMed |
| 6167846 | The interferon renaissance: molecular aspects of induction and action. | Microbiol Rev | 1981 | https://conductscience.org/library/papers/6167846 | PubMed |
| 6166003 | Inhibition of vaccinia mRNA methylation by 2',5'-linked oligo(adenylic acid) triphosphate. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6166003 | PubMed |
| 424314 | Metabolic stability of 2' 5'oligo (A) and activity of 2' 5'oligo (A)-dependent endonuclease in extracts of interferon-treated and control HeLa cells. | Nucleic Acids Res | 1979 | https://conductscience.org/library/papers/424314 | PubMed |
| 291897 | Interferon, double-stranded RNA, and RNA degradation: activation of an endonuclease by (2'-5')An. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/291897 | PubMed |
| 284384 | Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/284384 | PubMed |
| 228264 | An interferon-induced phosphodiesterase degrading (2'-5') oligoisoadenylate and the C-C-A terminus of tRNA. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/228264 | PubMed |
| 226962 | Kinetics of the induction of three translation-regulatory enzymes by interferon. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/226962 | PubMed |
| 114998 | Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/114998 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28606
GET https://conductscience.org/api/papers/v1/28606/authors